| Targeting CXCR4 and FAK reverses doxorubicin resistance and suppresses invasion in non-small cell lung carcinoma M Dragoj, Z Milosevic, J Bankovic, N Tanic, M Pesic, T Stankovic Cellular oncology 40, 47-62, 2017 | 40 | 2017 |
| In vitro biomimetic models for glioblastoma-a promising tool for drug response studies T Stanković, T Ranđelović, M Dragoj, SS Burić, L Fernández, I Ochoa, ... Drug Resistance Updates 55, 100753, 2021 | 38 | 2021 |
| Potential of the dual mTOR kinase inhibitor AZD2014 to overcome paclitaxel resistance in anaplastic thyroid carcinoma Z Milošević, J Banković, J Dinić, C Tsimplouli, E Sereti, M Dragoj, ... Cellular oncology 41, 409-426, 2018 | 28 | 2018 |
| Lower antioxidative capacity of multidrug-resistant cancer cells confers collateral sensitivity to protoflavone derivatives T Stanković, B Dankó, A Martins, M Dragoj, S Stojković, A Isaković, ... Cancer chemotherapy and pharmacology 76, 555-565, 2015 | 28 | 2015 |
| Chemo-protective and regenerative effects of diarylheptanoids from the bark of black alder (Alnus glutinosa) in human normal keratinocytes J Dinić, T Ranđelović, T Stanković, M Dragoj, A Isaković, M Novaković, ... Fitoterapia 105, 169-176, 2015 | 26 | 2015 |
| Novel TrxR1 inhibitors show potential for glioma treatment by suppressing the invasion and sensitizing glioma cells to chemotherapy M Jovanović, M Dragoj, D Zhukovsky, D Dar’in, M Krasavin, M Pešić, ... Frontiers in Molecular Biosciences 7, 586146, 2020 | 21 | 2020 |
| Association of overexpressed MYC gene with altered PHACTR3 and E2F4 genes contributes to non-small cell lung carcinoma pathogenesis M Dragoj, J Bankovic, A Podolski-Renic, SS Buric, M Pesic, N Tanic, ... Journal of Medical Biochemistry 38 (2), 188, 2019 | 20 | 2019 |
| Development and validation of a long-term 3D glioblastoma cell culture in alginate microfibers as a novel bio-mimicking model system for preclinical drug testing M Dragoj, J Stojkovska, T Stanković, J Dinić, A Podolski-Renić, ... Brain Sciences 11 (8), 1025, 2021 | 17 | 2021 |
| Anti-invasive effects of CXCR4 and FAK inhibitors in non-small cell lung carcinomas with mutually inactivated p53 and PTEN tumor suppressors M Dragoj, J Bankovic, E Sereti, SJ Stojanov, K Dimas, M Pesic, ... Investigational New Drugs 35 (6), 718-732, 2017 | 14 | 2017 |
| Association of CCND1 overexpression with KRAS and PTEN alterations in specific subtypes of non-small cell lung carcinoma and its influence on patients’ outcome M Dragoj, Z Milosevic, J Bankovic, J Dinic, M Pesic, N Tanic, T Stankovic Tumor Biology 36, 8773-8780, 2015 | 14 | 2015 |
| Pyrazolo[3,4-d]pyrimidine Tyrosine Kinase Inhibitors Induce Oxidative Stress in Patient-Derived Glioblastoma Cells A Kostić, S Jovanović Stojanov, A Podolski-Renić, M Nešović, M Dragoj, ... Brain Sciences 11 (7), 884, 2021 | 11 | 2021 |
| Molecular basis of brain injury and repair S Peković, S Dacić, N Nedeljković, I Bjelobaba, R Filipović, I Milenković, ... Neurobiological studies–From genes to behavior 2006, 143-165, 2006 | 11 | 2006 |
| Nano-motion analysis for rapid and label free assessing of cancer cell sensitivity to chemotherapeutics P Stupar, A Podolski-Renić, MI Villalba, M Dragoj, S Jovanović Stojanov, ... Medicina 57 (5), 446, 2021 | 7 | 2021 |
| Decreased TSPAN14 expression contributes to NSCLC progression M Jovanović, T Stanković, S Stojković Burić, J Banković, J Dinić, M Ljujić, ... Life 12 (9), 1291, 2022 | 6 | 2022 |
| On optimal temozolomide scheduling for slowly growing glioblastomas B Segura-Collar, J Jiménez-Sánchez, R Gargini, M Dragoj, ... Neuro-Oncology Advances 4 (1), vdac155, 2022 | 4 | 2022 |
| Chemosensitivity and survival of non-small cell lung carcinoma patients receiving neoadjuvant therapy depend on the expression of multidrug efflux transporters S Tijana, S Jelena, D Miodrag, M Zorka, M Zorica, M Vedrana, ST Vesna, ... Journal of Molecular and Clinical Medicine 2 (4), 129-135, 2019 | 2 | 2019 |
| Alpha-1 antitrypsin expression is upregulated in multidrug-resistant cancer cells A Divac Rankov, S Jovanović Stojanov, M Dragoj, M Ljujić Histochemistry and Cell Biology 159 (5), 431-437, 2023 | 1 | 2023 |
| Biomimetic tumor engineering to enhance drug discovery-BioengineeredTumor. B Obradović, J Stojkovska, J Zvicer, M Milivojević, R Janković, M Dragoj, ... Chemical Industry/Hemijska Industrija 78, 2024 | | 2024 |
| Adaptable alginate-based microfibers for 3D in vitro cultures of cancer cells: an anticancer drug testing model. J Petrović, E Pańczyszyn, M Corazzari, I Banićević, M Milivojević, L Bojić, ... Chemical Industry/Hemijska Industrija 78, 2024 | | 2024 |
| Immunofluorescence-Based Assay for High-Throughput Analysis of Multidrug Resistance Markers in Non-Small Cell Lung Carcinoma Patient-Derived Cells J Dinić, A Podolski-Renić, M Dragoj, S Jovanović Stojanov, A Stepanović, ... Diagnostics 13 (24), 3617, 2023 | | 2023 |
